The latest update is out from Kala Pharmaceuticals ( (KALA) ).
Mark S. Blumenkranz, M.D. has abruptly resigned from his positions on the Board of Directors, Audit Committee, and Nominating and Corporate Governance Committee of KALA BIO, Inc., effective immediately. His departure is noteworthy for not being linked to any disputes or disagreements with the company’s operations, policies, or practices.
See more data about KALA stock on TipRanks’ Stock Analysis page.
